Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07298408) titled 'Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Florida A&M University
Condition:
Diabetic Peripheral Neuropathic Pain (DPN)
Intervention:
Drug: Cannabidiol (CBD) oral solution
Drug: Full-Spectrum CBD hemp extract oral solution
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: January 2, 2026
Target Sample Size: 20 ...